Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Adagio Medical Holdings, Inc.ADGM · Entity 7926 | Director | June 16, 2026 | August 12, 2026 |
| Medtronic plcMDT · Entity 2888 | EVP & President Cardiovascular | December 16, 2024 | December 17, 2024 |
| TELEFLEX INCTFX · Entity 3798 | Director | September 08, 2026 | September 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Adagio Medical Holdings, Inc.
Report date June 16, 2026 · Filed August 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non-qualified stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.71 · Expires 2036-06-16 | Direct | 30,000 |
Reported balance
After 2026-06-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-16 · Grant · Acquired 30,000 · Balance 30,000 F1: Annual stock option granted under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the "Option"). The Option will vest in equal monthly installments over a one-year period, whereby 1/12th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of 06/16/2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Annual stock option granted under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the "Option"). The Option will vest in equal monthly installments over a one-year period, whereby 1/12th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of 06/16/2026.
Medtronic plc
Report date December 16, 2024 · Filed December 17, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 64,722 |
Reported balance
After 2024-12-16 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2024-12-16 · Tax withholding · Disposed 645 · Balance 64,722 F1: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I due to the reporting person's retirement eligibility. F2: Includes 257 shares acquired through dividend reinvestment since the last report filed by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I due to the reporting person's retirement eligibility.
F2: Includes 257 shares acquired through dividend reinvestment since the last report filed by the reporting person.
TELEFLEX INC
Report date September 08, 2026 · Filed September 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 674 |
Reported balance
After 2026-09-08 transaction · row 1
1 source rowRow 1 · 2026-09-08 · Grant · Acquired 674 · Balance 674 F1: Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan. Award vests 100% on the one-year anniversary of the grant date. |
| Stock Option / (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $137.00 · Expires 2036-09-08 | Direct | 4,444 |
Reported balance
After 2026-09-08 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-08 · Grant · Acquired 4,444 · Balance 4,444 F2: Stock Option Award vests 100% on the one-year anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan. Award vests 100% on the one-year anniversary of the grant date.
F2: Stock Option Award vests 100% on the one-year anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 02, 2021 Filed Aug 4, 2021 22:24 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 46,867 | $0.00 Strike: $131.26 | $0.00 |
DisclosureSEC source: 0001127602-21-023105 · form4.xml · derivative · entry 3 Salmon Sean · CIK 0001792380 · EVP & Pres Diabetes/Cardiovasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,867 Underlying: Ordinary Shares · 46,867 shares Expires 2031-08-02 F4 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 22:24 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 5,486 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-023105 · form4.xml · nonDerivative · entry 2 Salmon Sean · CIK 0001792380 · EVP & Pres Diabetes/Cardiovasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,329 F3 · kind: The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 22:24 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 2,272 | $131.31 | $298,336.32 |
DisclosureSEC source: 0001127602-21-023105 · form4.xml · nonDerivative · entry 1 Salmon Sean · CIK 0001792380 · EVP & Pres Diabetes/Cardiovasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,843 F1 · balance_after: This amount has been adjusted to correct a mathematical error in exempt transactions such as dividend reinvestment. F2 · balance_after: This balance increased by 163 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 22:46 UTC | Medtronic plc MDT · Entity 2888 | GrantPerformance Share Units · Derivative | 4,947 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-003781 · form4.xml · derivative · entry 3 Salmon Sean · CIK 0001792380 · EVP & Group President Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,947 Underlying: Performance Share Units · 4,947 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 4,947 shares will be issued. The actual number of shares to be issued could range from a low of 990 at minimum performance to a high of 9,894 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F5 · derivative.exercise_date: Vests on February 1, 2024. F5 · derivative.expiration_date: Vests on February 1, 2024. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 22:46 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 16,314 | $0.00 Strike: $111.18 | $0.00 |
DisclosureSEC source: 0001127602-21-003781 · form4.xml · derivative · entry 2 Salmon Sean · CIK 0001792380 · EVP & Group President Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,314 Underlying: Ordinary Shares · 16,314 shares Expires 2031-02-01 F2 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 22:46 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 1,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-003781 · form4.xml · nonDerivative · entry 1 Salmon Sean · CIK 0001792380 · EVP & Group President Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,007 F1 · balance_after: This balance increased by 128 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 23:09 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 220 | $103.13 | $22,688.60 |
DisclosureSEC source: 0001127602-20-028282 · form4.xml · nonDerivative · entry 1 Salmon Sean · CIK 0001792380 · EVP & Group President Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,900 F1 · balance_after: This balance increased by 79 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| October 09, 2020 Filed Oct 14, 2020 23:01 UTC | Medtronic plc MDT · Entity 2888 | GrantPerformance Share Units · Derivative | 11,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026959 · form4.xml · derivative · entry 1 Salmon Sean · CIK 0001792380 · EVP & Group President Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,042 Underlying: Performance Share Units · 11,042 shares Expires not disclosed F1 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F2 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 11,042 shares will be issued. The actual number of shares to be issued could range from a low of 2,209 at minimum performance to a high of 22,084 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F3 · derivative.exercise_date: Vests on August 3, 2023. F3 · derivative.expiration_date: Vests on August 3, 2023. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 21:06 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 30,227 | $0.00 Strike: $97.33 | $0.00 |
DisclosureSEC source: 0001127602-20-022918 · form4.xml · derivative · entry 4 Salmon Sean · CIK 0001792380 · EVP & Group President Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,227 Underlying: Ordinary Shares · 30,227 shares Expires 2030-08-03 F2 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 21:06 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 1,575 | $0.00 Strike: $97.33 | $0.00 |
DisclosureSEC source: 0001127602-20-022918 · form4.xml · derivative · entry 3 Salmon Sean · CIK 0001792380 · EVP & Group President Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,575 Underlying: Ordinary Shares · 1,575 shares Expires 2030-08-03 F2 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 21:06 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 45,340 | $0.00 Strike: $97.33 | $0.00 |
DisclosureSEC source: 0001127602-20-022918 · form4.xml · derivative · entry 2 Salmon Sean · CIK 0001792380 · EVP & Group President Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,340 Underlying: Ordinary Shares · 45,340 shares Expires 2030-08-03 F2 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 21:06 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 4,932 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-022918 · form4.xml · nonDerivative · entry 1 Salmon Sean · CIK 0001792380 · EVP & Group President Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,041 F1 · kind: The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date. Read SEC document |
| July 31, 2020 Filed Aug 3, 2020 21:59 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 2,569 | $96.48 | $247,857.12 |
DisclosureSEC source: 0001127602-20-022606 · form4.xml · nonDerivative · entry 1 Salmon Sean · CIK 0001792380 · EVP & Group President Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,109 F1 · balance_after: This balance increased by 269 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.